Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
Raquel Ortiz(Universitat Autònoma de Barcelona), Julià Blanco(IrsiCaixa)
Cited by 11
Related Papers
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
|The EMBO Journal|2002|147
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
|Journal of Antimicrobial Chemotherapy|2015|65
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
|npj Vaccines|2023|34